Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
CHIMERIC 7E3 PREVENTS CAROTID-ARTERY THROMBOSIS IN CYNOMOLGUS MONKEYS
Autore:
ROTE WE; NEDELMAN MA; MU DX; MANLEY PJ; WEISMAN H; CUNNINGHAM MR; LUCCHESI BR;
Indirizzi:
UNIV MICHIGAN,SCH MED,DEPT PHARMACOL,M6322 MED SCI 1 ANN ARBOR MI 48108 UNIV MICHIGAN,SCH MED,DEPT PHARMACOL ANN ARBOR MI 48108 CENTOCOR INC MALVERN PA 00000
Titolo Testata:
Stroke
fascicolo: 6, volume: 25, anno: 1994,
pagine: 1223 - 1232
SICI:
0039-2499(1994)25:6<1223:C7PCTI>2.0.ZU;2-M
Fonte:
ISI
Lingua:
ENG
Soggetto:
INDUCED PLATELET-AGGREGATION; ACUTE MYOCARDIAL-INFARCTION; GPIIB-IIIA RECEPTOR; PLASMINOGEN-ACTIVATOR; GLYCOPROTEIN-IIB/IIIA; MACACA-FASCICULARIS; ISCHEMIC STROKE; CONJUNCTIVE THERAPY; FIBRINOGEN RECEPTOR; MONOCLONAL-ANTIBODY;
Keywords:
ANTITHROMBOTIC THERAPY; ASPIRIN; PLATELET AGGREGATION; MONKEYS;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Science Citation Index Expanded
Citazioni:
57
Recensione:
Indirizzi per estratti:
Citazione:
W.E. Rote et al., "CHIMERIC 7E3 PREVENTS CAROTID-ARTERY THROMBOSIS IN CYNOMOLGUS MONKEYS", Stroke, 25(6), 1994, pp. 1223-1232

Abstract

Background and Purpose We compared the current antithrombotic strategy of antiplatelet therapy with aspirin, and anticoagulant therapy withheparin, with a specific genetically engineered chimeric antibody (c7E3 Fab) directed against the human glycoprotein IIb/IIIa receptor in an animal model of arterial thrombosis. Methods Anesthetized cynomolgusmonkeys (Macaca fascicularis) were instrumented for monitoring of arterial blood pressure, heart rate, and carotid artery flow velocity. Animals were treated with saline (n=6), aspirin (25 mg PO daily for 3 days; n=6), heparin (100 U/kg IV plus infusion adjusted to maintain activated partial thromboplastin time at 2 to 3 times baseline; n=6), aspirin plus heparin (as administered separately, n=6), or c7E3 Fab (0.10 mg/kg IV, n=7; 0.15 mg/kg IV, n=6; 0.20 mg/kg IV, n=6; 0.25 mg/kg IV, n=6). Thrombus formation via anodal electrolytic stimulation (100 mu A) to the intimal surface of the right carotid artery was initiated 15 minutes after drug administration and continued for 180 minutes. Electrolytic injury to the left carotid artery began 210 minutes after drugadministration and continued for 180 minutes. Whole blood cell counts, glycoprotein IIb/lIIa receptor blockade, ex vivo platelet aggregation, template bleeding time, and activated partial thromboplastin time were assessed at various time points throughout the experimental protocol. Results Hemodynamic and hematologic parameters were comparable among groups at baseline. Treatment with c7E3 Fab inhibited ex vivo platelet aggregation, increased bleeding time, decreased thrombus weight, and increased time to occlusion in a dose-dependent manner in both vessels. Treatment with aspirin, heparin, or the combination of aspirin plus heparin was ineffective for the prevention of carotid artery thrombosis in this model. Conclusions Inhibition of the platelet glycoprotein IIb/IIIa receptor with c7E3 Fab was found to be safe and effective for the prevention of primary thrombus formation, whereas treatment with either aspirin or heparin or the combination of the two agents failed to protect against occlusive thrombus formation in cynomolgus monkeys.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/12/20 alle ore 03:59:25